TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15021 · Aug 1

#go#argocd#cloud_native#cncf#container_management#devops#ebpf#hacktoberfest#istio#jenkins#k8s#kubernetes#kubernetes_platform_solution#kubesphere#llm#multi_cluster#observability#servicemesh KubeSphere is an easy-to-use, open-source platform that helps you manage Kubernetes clusters across clouds, data centers, and edge devices from one place. It offers a friendly web interface, supports multi-cluster and multi-tenant management, and automates DevOps tasks like CI/CD pipelines. You get built-in monitoring, logging, alerting, and security features such as role-based access control. It also includes an App Store for quick deployment of applications and supports various storage and networking options. This makes managing complex Kubernetes environments simpler, faster, and more secure, saving you time and reducing operational challenges. https://github.com/kubesphere/kubesphere

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment